132 related articles for article (PubMed ID: 23175274)
21. [Whole-body MR diagnostic concepts].
Ladd SC; Zenge M; Antoch G; Forsting M
Rofo; 2006 Aug; 178(8):763-70. PubMed ID: 16862502
[TBL] [Abstract][Full Text] [Related]
22. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
[TBL] [Abstract][Full Text] [Related]
23. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.
Hamaguchi M; Takeda N; Kojima T; Ohbora A; Kato T; Sarui H; Fukui M; Nagata C; Takeda J
World J Gastroenterol; 2012 Apr; 18(13):1508-16. PubMed ID: 22509083
[TBL] [Abstract][Full Text] [Related]
24. Voxel-wise Study of Cohort Associations in Whole-Body MRI: Application in Metabolic Syndrome and Its Components.
Lind L; Strand R; Michaëlsson K; Ahlström H; Kullberg J
Radiology; 2020 Mar; 294(3):559-567. PubMed ID: 31891319
[TBL] [Abstract][Full Text] [Related]
25. Modulating Diffusion-Weighted Magnetic Resonance Imaging for Screening in Oncologic Tertiary Prevention: A Prospective Ex Vivo and In Vivo Study.
Dreher C; Kuder TA; König F; Paech D; Tavakoli A; Laun FB; Flothow F; Gnirs R; Benkert T; Nickel D; Strecker R; Schlemmer HP; Bickelhaupt S
Invest Radiol; 2019 Nov; 54(11):704-711. PubMed ID: 31356384
[TBL] [Abstract][Full Text] [Related]
26. Findings in whole body MRI and conventional imaging in patients with fever of unknown origin-a retrospective study.
Tavakoli AA; Reichert M; Blank T; Dinter D; Weckbach S; Buchheidt D; Schoenberg SO; Attenberger U
BMC Med Imaging; 2020 Aug; 20(1):94. PubMed ID: 32767967
[TBL] [Abstract][Full Text] [Related]
27. Detection of cardiovascular disease in elite athletes using cardiac magnetic resonance imaging.
Mangold S; Kramer U; Franzen E; Erz G; Bretschneider C; Seeger A; Claussen CD; Niess AM; Burgstahler C
Rofo; 2013 Dec; 185(12):1167-74. PubMed ID: 23897528
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Acoustic Radiation Force Impulse (ARFI) imaging and contrast-enhanced ultrasound in renal tumors of unknown etiology in comparison to histological findings.
Clevert DA; Stock K; Klein B; Slotta-Huspenina J; Prantl L; Heemann U; Reiser M
Clin Hemorheol Microcirc; 2009; 43(1-2):95-107. PubMed ID: 19713604
[TBL] [Abstract][Full Text] [Related]
29. Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
Min LA; Vogel WV; Lahaye MJ; Maas M; Donswijk ML; Vegt E; Kusters M; Zijlmans HJ; Jóźwiak K; Roberti S; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2019 Dec; 29(12):6900-6910. PubMed ID: 31119418
[TBL] [Abstract][Full Text] [Related]
30. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
31. Whole-body screening of atherosclerosis with magnetic resonance angiography.
Hansen T; Ahlström H; Johansson L
Top Magn Reson Imaging; 2007 Oct; 18(5):329-37. PubMed ID: 18025987
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients.
Ohno Y; Nishio M; Koyama H; Yoshikawa T; Matsumoto S; Takenaka D; Seki S; Tsubakimoto M; Sugimura K
Eur J Radiol; 2013 Nov; 82(11):2018-27. PubMed ID: 24012452
[TBL] [Abstract][Full Text] [Related]
33. Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol.
Schramm N; Born C; Weckbach S; Reilich P; Walter MC; Reiser MF
Eur Radiol; 2008 Dec; 18(12):2922-36. PubMed ID: 18648820
[TBL] [Abstract][Full Text] [Related]
34. Improving the follow up after EVAR by using ultrasound image fusion of CEUS and MS-CT.
Clevert DA; Helck A; D'Anastasi M; Gürtler V; Sommer WH; Meimarakis G; Weidenhagen R; Reiser M
Clin Hemorheol Microcirc; 2011; 49(1-4):91-104. PubMed ID: 22214681
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging for lung cancer detection: experience in a population of more than 10,000 healthy individuals.
Wu NY; Cheng HC; Ko JS; Cheng YC; Lin PW; Lin WC; Chang CY; Liou DM
BMC Cancer; 2011 Jun; 11():242. PubMed ID: 21668954
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
[TBL] [Abstract][Full Text] [Related]
37. Emerging techniques: whole-body screening and staging with MRI.
Lauenstein TC; Semelka RC
J Magn Reson Imaging; 2006 Sep; 24(3):489-98. PubMed ID: 16888774
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of color duplex ultrasound diagnosis of spontaneous carotid dissection causing ischemia.
Benninger DH; Georgiadis D; Gandjour J; Baumgartner RW
Stroke; 2006 Feb; 37(2):377-81. PubMed ID: 16373650
[TBL] [Abstract][Full Text] [Related]
39. Echoscopy in scanning abdominal diseases in a critical care setting.
Wastl D; Löwe A; Dietrich CF
Med Klin Intensivmed Notfmed; 2023 Apr; 118(3):228-235. PubMed ID: 35652927
[TBL] [Abstract][Full Text] [Related]
40. Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.
Nakanishi K; Kobayashi M; Takahashi S; Nakata S; Kyakuno M; Nakaguchi K; Nakamura H
Magn Reson Med Sci; 2005; 4(1):11-7. PubMed ID: 16127249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]